Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Dialysis access · New Jersey | Dialysis access · New York | |
|---|---|---|
| Surgeons, 2024 | 58 | 109 |
| Medicare fee-for-service cases | 7,071 | 13,452 |
| Growth since 2019 (Medicare FFS) | −13%/yr | −13%/yr |
| Forecast cases (Medicare FFS) | 7,590 in 2030 | 12,500 in 2030 |
| Forecast growth | +1.2%/yr to 2030 | −1.2%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 7.0 | 7.7 |
| Medicare Advantage share | 45% | 57% |
| Out of hospital | 70% (−1 pts since 2019) | 80% (+4 pts since 2019) |
| Cases per surgeon | 122 | 123 |
| Top 10 surgeons' share | 68% | 43% |
| Surgeons growing | 4 | 10 |
| New since the base year | 6 | 17 |
| Likely to stop billing it | 10 by 2026 | 24 by 2026 |
| Forecast miss, 1 year (procedure) | 4% | 4% |
| Company payments per surgeon | $118 | $100 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.